EN DE

Colgate-Palmolive Company (CL) Fair Value & Analysis

Consumer Defensive · US · Market cap $73.8B

CP Colgate-Palmolive Company logo Colgate-Palmolive Company CL · US
Price$93.00
Fair Value$55.95
Upside-39.8%
Quality73/100
Watch Colgate-Palmolive Company for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 10.0% net margin
High debt · generates free cash flow
2.29% dividend yield
Mixed vs. peers (7/14)
Wide moat 82/100
Evidence: High Range $38.69 – $69.94 Share as image

Fair value as of: Jul 11, 2026

From 25 valuation models · updated 27 days ago

Share price −2.1% over the past month.

A solid business, but screening 40% overvalued on our models.

What matters now

  • A high-quality business (quality 73/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case ($69.94). The favourable scenario is already priced in.
  • A fairly wide model range ($38.69 to $69.94) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$104.38 $62.58 Fair Value $55.95 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.

How to read this chart

60‑month range $62.58 – $104.38 · fair‑value band $38.69 – $69.94 · the $93.00 price screens above the $55.95 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 11, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Colgate-Palmolive Company (CL) currently trades at $93.00, while our model-based Fair Value estimate is $55.95, implying the stock looks roughly 39.8% overvalued today. We read business quality at 73/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Colgate-Palmolive Company generated revenue of $20.8B at a net margin of 10.0%. Revenue grew 8.4% year over year. It earns a return on equity of 36.4%. Net debt stands at $6.7B. Fundamentals as of Jul 11, 2026

Our scenario range runs from $38.69 (bear case) to $69.94 (bull case); at $93.00, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 6% below its 52-week high and 26% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -40%, CL screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $41.98 $60.28 $84.85 80
Residual Income $1.61 $1.93 $9.96 76
Rev-Margin DCF $36.74 $58.36 $80.98 74
All 25 models by family
DCF Models
FCF DCF $40.40 $59.72 $86.65 38
Owner Earnings $21.68 $33.37 $49.65 31
5Y Revenue Exit $36.74 $57.70 $83.14 39
5Y EBITDA Exit $43.83 $70.11 $98.95 41
5Y P/E Exit $32.45 $50.21 $67.45 38
10Y Revenue Exit $36.44 $55.26 $77.74 36
10Y EBITDA Exit $42.11 $63.57 $89.09 37
10Y P/E Exit $35.04 $50.24 $66.49 35
Earnings-Based
Graham-Dodd $18.12 $37.83 $47.85 54
PEG = 1.0 $5.61 $8.02 $10.43 46
EPV $35.27 $42.32 $48.48 59
Dividend Discount
Gordon GGM $20.92 $31.33 $42.37 70
DDM Multi-Stage $20.92 $29.82 $40.01 61
Multiples
P/E Multiple $39.97 $53.29 $66.61 63
P/S Multiple $33.97 $45.29 $56.62 58
P/B Multiple $1.03 $1.37 $1.71 55
EV/EBIT $66.38 $90.83 $115.28 53
EV/EBITDA $53.68 $73.90 $94.11 54
EV/Revenue $37.60 $56.70 $75.81 43
Asset-Based
NCAV (Graham) $0.2300 $0.3100 $0.4600 50
Growth DCF
Growth DCF $41.98 $60.28 $84.85 80
Rev-Margin DCF $36.74 $58.36 $80.98 74
Economic Profit
Residual Income $1.61 $1.93 $9.96 76
ROIC Compounder $36.08 $44.22 $52.00 72
Growth Earnings
Growth-Adj P/E $29.37 $41.95 $54.54 68

Widest divergence: Growth DCF ($58.36) versus Asset-Based ($0.3100). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $20.8B
Revenue growth (YoY) +8.4%
Net margin 10.0%
Return on equity 36.4%
Free cash flow $3.6B FY2025
P/E ratio 35.3
More key figures
Operating margin 20.9%
EPS (TTM) $2.61
Dividend yield 2.3%
EPS growth (YoY) -5.9%
Net debt $6.7B FY2025

Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 73/100

Of which business quality 71 · Market factors (momentum, volatility) 66

Profitability 84
Margins and returns on capital today
Quality Growth 24
Are margins and returns improving?
Cashflow 83
Earnings quality: real cash, not paper profit
Fin. Strength 45
Balance sheet, leverage, solvency risk
Investment 97
Disciplined investing over empire-building
Low Volatility 92
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 63
Distance to the 52-week high (market factor)
Net Issuance 94
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.

Full company description

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Colgate-Palmolive Company reported revenue of $20.4B in FY2025 versus $17.4B in FY2021, a compound +4.0%/yr. Reported net income was $2.1B in FY2025, compounding −0.4%/yr from FY2021.

Growth Quality 77/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$20.4B
Latest YoY
+1.4%
Avg. growth/yr (3Y)
+4.3%
Avg. growth/yr (5Y)
+4.4%
Avg. growth/yr (40Y)
+3.8%
Revenue +4.0%/yr
FY21 $17.4B
FY22 $18.0B
FY23 $19.5B
FY24 $20.1B
FY25 $20.4B
Net income −0.4%/yr
FY21 $2.2B
FY22 $1.8B
FY23 $2.3B
FY24 $2.9B
FY25 $2.1B

CL screens 40% overvalued. Compare with The Procter & Gamble Company →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Colgate-Palmolive Company Fair Value". https://www.fairvalue-calculator.com/stock/CL

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 73 · Top 25%
Fair Value upside −40% · Below median
Return on equity (TTM) 36% · Top 25%
Return on assets 16% · Top 25%
Net margin (TTM) 10% · Above median
Operating margin (TTM) 21% · Top 25%
Revenue growth 8% · Top 25%
Dividend yield (TTM) 2.3% · Below median
Debt / equity 18.83× · Higher than 75% of peers

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 35.3× · Pricier than 75% of peers
P/S (TTM) 3.55× · Pricier than 75% of peers
P/FCF 20.3× · Pricier than 75% of peers
EV/EBITDA 16.1× · Pricier than median
PEG 1.66× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 29
FUTURE 42 · sector 4
PAST 100 · sector 27
HEALTH 0 · sector 98
DIVIDEND 46 · sector 50

VALUE 0: the price sits above our fair-value range.

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare Colgate-Palmolive Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Colgate-Palmolive Company (CL) overvalued or undervalued?
As of Jul 11, 2026, our model estimates a fair value of $55.95 versus a price of $93.00, about −40% (overvalued).
What is the fair value of CL?
Our model-based fair value for Colgate-Palmolive Company is $55.95 (as of Jul 11, 2026), built from audited fundamentals. The current price is $93.00.
What is the quality score of CL?
Colgate-Palmolive Company has a Quality Score of 73/100. It combines two groups: business quality (profitability, growth, cash flow, balance-sheet strength) and market factors (price momentum, distance to the 52-week high, volatility). Both subtotals are shown separately in the detail view.
What is the revenue of Colgate-Palmolive Company (CL)?
Colgate-Palmolive Company reported trailing-twelve-month revenue of about $20.8B (latest available figure, as of Jul 11, 2026).
What is the net profit margin of CL?
The net profit margin of Colgate-Palmolive Company is about 10.0%, meaning it keeps roughly 10.0% of revenue as net income. Based on the latest reported figures.
Does Colgate-Palmolive Company pay a dividend?
Colgate-Palmolive Company currently shows a dividend yield of about 2.45% relative to its recent price (as of Jul 11, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Colgate-Palmolive Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.